Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$515.48M
Total Bought:
$131.11M
Total Sold:
$194.28M
Net Transaction:
-$63.16M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Lakefront Biotherapeutics NVADR(LKFT)2,043,3441,998,400-44,944$61.26M$59.25M11.49%-$2.01M
Shattuck Labs, Inc.(STTK)5,957,8777,648,094+1,690,217$41.35M$52.16M10.12%+$10.81M
Janux Therapeutics, Inc.(JANX)3,804,4812,943,200-861,281$58.44M$50.86M9.87%-$7.58M
Nektar Therapeutics(NKTR)810,000785,000-25,000$56.55M$47.53M9.22%-$9.02M
ABIVAX Société AnonymeADS(ABVX)107,394376,794+269,400$14.31M$37.31M7.24%+$23.00M
Insmed Incorporated(INSM)375,609238,088-137,521$40.05M$27.18M5.27%-$12.87M
Boston Scientific Corporation(BSX)1,270,273550,000-720,273$54.22M$24.01M4.66%-$30.21M
iRhythm Holdings, Inc.(IRTC)165,500200,980+35,480$19.69M$22.84M4.43%+$3.16M
Alkermes plcSHS(ALKS)394,389550,000+155,611$20.66M$22.29M4.32%+$1.62M
Privia Health Group, Inc.(PRVA)01,049,752+1,049,752$0$20.67M4.01%+$20.67M
Mineralys Therapeutics, Inc.(MLYS)449,795800,000+350,205$12.14M$20.10M3.90%+$7.97M
Zymeworks Inc.(ZYME)674,434721,100+46,666$17.63M$19.10M3.71%+$1.47M
Syndax Pharmaceuticals, Inc.(SNDX)1,200,000812,582-387,418$26.23M$15.28M2.96%-$10.96M
Kura Oncology, Inc.(KURA)2,021,9641,275,000-746,964$22.18M$13.66M2.65%-$8.53M
Denali Therapeutics Inc.(DNLI)0550,700+550,700$0$11.38M2.21%+$11.38M
Praxis Precision Medicines, Inc.(PRAX)036,400+36,400$0$10.60M2.06%+$10.60M
HealthEquity, Inc.(HQY)0115,796+115,796$0$10.24M1.99%+$10.24M
BridgeBio Pharma, Inc.(BBIO)0150,000+150,000$0$9.87M1.91%+$9.87M
Alnylam Pharmaceuticals, Inc.(ALNY)98,08037,000-61,080$29.53M$9.13M1.77%-$20.40M
Humana Inc.(HUM)022,000+22,000$0$8.39M1.63%+$8.39M
Enovis Corporation(ENOV)0267,432+267,432$0$4.89M0.95%+$4.89M
OnKure Therapeutics, Inc.CL A(OKUR)978,9921,325,570+346,578$4.46M$3.61M0.70%-$852.0K
Quanterix Corporation(QTRX)0825,000+825,000$0$3.06M0.59%+$3.06M
Generate Biomedicines, Inc.(GENB)0144,756+144,756$0$2.17M0.42%+$2.17M
An2 Therapeutics Inc474,638350,877-123,761$2.30M$1.87M0.36%-$430.6K
Pliant Therapeutics, Inc.(PLRX)1,370,2331,604,466+234,233$1.56M$1.73M0.34%+$170.8K
Rocket Pharmaceuticals, Inc.(RCKT)700,000595,024-104,976$2.39M$1.56M0.30%-$829.1K
Rein Therapeutics Inc.(RNTX)1,100,0001,660,197+560,197$1.14M$1.33M0.26%+$190.8K
Coya Therapeutics, Inc.(COYA)170,000229,600+59,600$994.5K$1.15M0.22%+$155.8K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)650,000168,383-481,617$6.10M$1.15M0.22%-$4.95M
Immuneering CorpCL A36,861150,000+113,139$183.9K$614.3K0.12%+$430.3K
ADC Therapeutics SASHS(ADCT)7,824,749399,900-7,424,849$8.37M$487.9K0.09%-$7.88M
Crinetics Pharmaceuticals In374,6660-374,666$14.02M$0—-$14.02M
Emergent BioSolutions Inc.(EBS)459,9520-459,952$3.85M$0—-$3.85M
Everforth, Inc.(EFOR)67,5000-67,500$1.21M$0—-$1.21M
GeneDx Holdings Corp.CL A(WGS)85,5000-85,500$5.87M$0—-$5.87M
ICU Medical, Inc.(ICUI)51,0000-51,000$7.48M$0—-$7.48M
Intuitive Surgical, Inc.(ISRG)17,0000-17,000$6.76M$0—-$6.76M
MeiraGTx Holdings plc(MGTX)90,0000-90,000$1.22M$0—-$1.22M
Option Care Health, Inc.(OPCH)270,7160-270,716$5.68M$0—-$5.68M
OrthoPediatrics Corp.(KIDS)157,5000-157,500$3.01M$0—-$3.01M
Pfizer Inc.(PFE)135,3660-135,366$3.26M$0—-$3.26M
PROCEPT BioRobotics Corporation(PRCT)268,2690-268,269$6.06M$0—-$6.06M
Tectonic Therapeutic, Inc.(TECX)39,7310-39,731$1.37M$0—-$1.37M
Veeva Systems Inc.CL A(VEEV)106,2000-106,200$18.85M$0—-$18.85M
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q3 2026 | TickerTrail